A Phase 2, randomized, double-blind, placebo-controlled trial to investigate the efficacy and safety of 2 doses of vipoglanstat in patients with moderate to severe endometriosis-related pain – the NOVA trial (The NOVA trial)

Principal Investigator

Prof Christian M Becker

Contact us

Email: osprea@wrh.ox.ac.uk

IRAS number

1012480